BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 2005;42:358-64. [PMID: 15710218 DOI: 10.1016/j.jhep.2004.11.020] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Kwee SA, Hernandez B, Chan O, Wong L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival. PLoS One. 2012;7:e46591. [PMID: 23071593 DOI: 10.1371/journal.pone.0046591] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
2 Zhong JT, Zhou SH. Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma. Oncotarget 2017;8:14133-46. [PMID: 27823965 DOI: 10.18632/oncotarget.13044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
3 Choi YH, Chung JW, Son KR, So YH, Kim W, Yoon CJ, Yoon JH, Chung H, Kim H, Jae HJ, Kim YI, Park JH. Novel Intraarterial Therapy for Liver Cancer Using Ethylbromopyruvate Dissolved in an Iodized Oil. Academic Radiology 2011;18:471-8. [DOI: 10.1016/j.acra.2010.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
4 Jae HJ, Chung JW, Park HS, Lee MJ, Lee KC, Kim HC, Yoon JH, Chung H, Park JH. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model. Korean J Radiol. 2009;10:596-603. [PMID: 19885316 DOI: 10.3348/kjr.2009.10.6.596] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
5 Cervello M, Bachvarov D, Lampiasi N, Cusimano A, Azzolina A, McCubrey JA, Montalto G. Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle. 2012;11:2843-2855. [PMID: 22801548 DOI: 10.4161/cc.21193] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 8.5] [Reference Citation Analysis]
6 Chen C, Lou T. Hypoxia inducible factors in hepatocellular carcinoma. Oncotarget 2017;8:46691-703. [PMID: 28493839 DOI: 10.18632/oncotarget.17358] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 15.5] [Reference Citation Analysis]
7 Mello T, Simeone I, Galli A. Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring. Cells 2019;8:E417. [PMID: 31060333 DOI: 10.3390/cells8050417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
8 Xintaropoulou C, Ward C, Wise A, Marston H, Turnbull A, Langdon SP. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget 2015;6:25677-95. [PMID: 26259240 DOI: 10.18632/oncotarget.4499] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
9 Rodrigues-ferreira C, da Silva APP, Galina A. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase. J Bioenerg Biomembr 2012;44:39-49. [DOI: 10.1007/s10863-012-9413-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
10 Kim JS, Ahn KJ, Kim JA, Kim HM, Lee JD, Lee JM, Kim SJ, Park JH. Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA. J Bioenerg Biomembr. 2008;40:607-618. [PMID: 19067133 DOI: 10.1007/s10863-008-9188-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
11 Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang HF, Ji ZZ, Guan HT, Wang XJ. Up-regulation of hypoxia inducible factor-1α by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells. J Exp Clin Cancer Res 2012;31:28. [PMID: 22453051 DOI: 10.1186/1756-9966-31-28] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
12 Wan J, Wu W, Chen Y, Kang N, Zhang R. Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals. Acta Biochim Biophys Sin (Shanghai) 2016;48:371-7. [PMID: 26922319 DOI: 10.1093/abbs/gmw005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mamori S, Tajiri H. Ets-1 is increased in anticancer drug-containing media and hypoxic cultures, similar to TACE. Scand J Gastroenterol 2009;44:507-8. [PMID: 19107674 DOI: 10.1080/00365520802647442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Yu SJ, Yoon JH, Yang JI, Cho EJ, Kwak MS, Jang ES, Lee JH, Kim YJ, Lee HS, Kim CY. Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition. J Bioenerg Biomembr. 2012;44:101-115. [PMID: 22350012 DOI: 10.1007/s10863-012-9416-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
15 Stany MP, Vathipadiekal V, Ozbun L, Stone RL, Mok SC, Xue H, Kagami T, Wang Y, McAlpine JN, Bowtell D, Gout PW, Miller DM, Gilks CB, Huntsman DG, Ellard SL, Wang YZ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Birrer MJ. Identification of novel therapeutic targets in microdissected clear cell ovarian cancers. PLoS One 2011;6:e21121. [PMID: 21754983 DOI: 10.1371/journal.pone.0021121] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
16 Dukhande VV, Sharma GC, Lai JCK, Farahani R. Chronic hypoxia-induced alterations of key enzymes of glucose oxidative metabolism in developing mouse liver are mTOR dependent. Mol Cell Biochem 2011;357:189-97. [DOI: 10.1007/s11010-011-0889-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
17 Speicher T, Foehrenbacher A, Pochic I, Weiland T, Wendel A. Malignant but not naïve hepatocytes of human and rodent origin are killed by TNF after metabolic depletion of ATP by fructose. J Hepatol 2010;53:896-902. [PMID: 20800309 DOI: 10.1016/j.jhep.2010.05.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Yoo JJ, Lee DH, Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY, Yoon JH. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions. J Bioenerg Biomembr 2016;48:581-90. [PMID: 27640193 DOI: 10.1007/s10863-016-9677-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kim YI, Chung JW. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery. Expert Rev Gastroenterol Hepatol 2008;2:791-802. [PMID: 19090739 DOI: 10.1586/17474124.2.6.791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Cho Y, Yoon JH, Yoo JJ, Lee M, Lee DH, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY. Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharm Sin B 2015;5:544-53. [PMID: 26713269 DOI: 10.1016/j.apsb.2015.09.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
21 Yoo JJ, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee JH, Kim YJ, Youn H, Yoon JH. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1292. [PMID: 30875800 DOI: 10.3390/ijms20061292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
22 Guzman G, Chennuri R, Chan A, Rea B, Quintana A, Patel R, Xu PZ, Xie H, Hay N. Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma. Dig Dis Sci 2015;60:420-6. [PMID: 25381201 DOI: 10.1007/s10620-014-3364-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
23 Surlis C, Carolan JC, Coffey M, Kavanagh K. Quantitative proteomics reveals divergent responses in Apis mellifera worker and drone pupae to parasitization by Varroa destructor. Journal of Insect Physiology 2018;107:291-301. [DOI: 10.1016/j.jinsphys.2017.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Eimre M, Paju K, Pelloux S, Beraud N, Roosimaa M, Kadaja L, Gruno M, Peet N, Orlova E, Remmelkoor R, Piirsoo A, Saks V, Seppet E. Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes. Biochim Biophys Acta 2008;1777:514-24. [PMID: 18423391 DOI: 10.1016/j.bbabio.2008.03.019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
25 Zhu H, Shao Q, Sun X, Deng Z, Yuan X, Zhou X, Ding Y. Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;27:1241-1251. [PMID: 22142567 DOI: 10.1111/j.1440-1746.2011.07044.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
26 Sun YD, Zhang H, Chen YQ, Wu CX, Chen ML, Xu HR, Wang S, Liu JZ, Han JJ. Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1. BMC Cancer 2021;21:1063. [PMID: 34583662 DOI: 10.1186/s12885-021-08783-8] [Reference Citation Analysis]
27 Verma M, Shulga N, Pastorino JG. Sirtuin-3 modulates Bak- and Bax-dependent apoptosis. J Cell Sci 2013;126:274-88. [PMID: 23108666 DOI: 10.1242/jcs.115188] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
28 Barrak NH, Khajah MA, Luqmani YA. Hypoxic environment may enhance migration/penetration of endocrine resistant MCF7- derived breast cancer cells through monolayers of other non-invasive cancer cells in vitro. Sci Rep 2020;10:1127. [PMID: 31980706 DOI: 10.1038/s41598-020-58055-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Bonora M, Pinton P. The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front Oncol 2014;4:302. [PMID: 25478322 DOI: 10.3389/fonc.2014.00302] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
30 Cho EJ, Yu SJ, Kim K, Cho H, Cho YY, Lee YB, Lee J, Kim YJ, Youn H, Yoon J. Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model. J Bioenerg Biomembr 2019;51:121-9. [DOI: 10.1007/s10863-019-09788-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Huang T, Civelek AC, Li J, Jiang H, Ng CK, Postel GC, Shen B, Li XF. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer. J Nucl Med. 2012;53:1262-1268. [PMID: 22717978 DOI: 10.2967/jnumed.111.098087] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
32 Kim BH, Yoon J, Myung SJ, Lee J, Lee S, Lee S, Lee H. Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells. Cancer Letters 2009;274:259-65. [DOI: 10.1016/j.canlet.2008.09.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Pan F, Lin XR, Hao LP, Chu XY, Wan HJ, Wang R. The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives. Front Cell Dev Biol 2021;9:674919. [PMID: 34046411 DOI: 10.3389/fcell.2021.674919] [Reference Citation Analysis]
34 Zhao X, Liu L, Li R, Wei X, Luan W, Liu P, Zhao J. Hypoxia-Inducible Factor 1-α (HIF-1α) Induces Apoptosis of Human Uterosacral Ligament Fibroblasts Through the Death Receptor and Mitochondrial Pathways. Med Sci Monit 2018;24:8722-33. [PMID: 30504760 DOI: 10.12659/MSM.913384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
35 Monge C, Beraud N, Tepp K, Pelloux S, Chahboun S, Kaambre T, Kadaja L, Roosimaa M, Piirsoo A, Tourneur Y, Kuznetsov AV, Saks V, Seppet E. Comparative analysis of the bioenergetics of adult cardiomyocytes and nonbeating HL-1 cells: respiratory chain activities, glycolytic enzyme profiles, and metabolic fluxes. Can J Physiol Pharmacol 2009;87:318-26. [PMID: 19370085 DOI: 10.1139/Y09-018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
36 Godinot C, de Laplanche E, Hervouet E, Simonnet H. Actuality of Warburg’s views in our understanding of renal cancer metabolism. J Bioenerg Biomembr 2007;39:235-41. [DOI: 10.1007/s10863-007-9088-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
37 Yan W, Han P, Zhou Z, Tu W, Liao J, Li P, Liu M, Tian D, Fu Y. Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness. Dig Dis Sci 2014;59:1213-21. [PMID: 24442237 DOI: 10.1007/s10620-013-3016-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
38 Yu SJ, Yoon JH, Lee JH, Myung SJ, Jang ES, Kwak MS, Cho EJ, Jang JJ, Kim YJ, Lee HS. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Acta Pharmacol Sin 2011;32:912-20. [PMID: 21666701 DOI: 10.1038/aps.2011.24] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
39 Wilson GK, Tennant DA, McKeating JA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J Hepatol. 2014;61:1397-1406. [PMID: 25157983 DOI: 10.1016/j.jhep.2014.08.025] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 11.8] [Reference Citation Analysis]
40 Lee M, Yoon JH. Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication. World J Biol Chem 2015; 6(3): 148-161 [PMID: 26322173 DOI: 10.4331/wjbc.v6.i3.148] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 73] [Article Influence: 11.7] [Reference Citation Analysis]
41 Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, da-Silva WS, Almeida FC, Da Poian AT, Galina A. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J. 2009;417:717-726. [PMID: 18945211 DOI: 10.1042/bj20080805] [Cited by in Crossref: 119] [Cited by in F6Publishing: 62] [Article Influence: 9.2] [Reference Citation Analysis]
42 Seppet E, Gruno M, Peetsalu A, Gizatullina Z, Nguyen HP, Vielhaber S, Wussling MH, Trumbeckaite S, Arandarcikaite O, Jerzembeck D, Sonnabend M, Jegorov K, Zierz S, Striggow F, Gellerich FN. Mitochondria and energetic depression in cell pathophysiology. Int J Mol Sci 2009;10:2252-303. [PMID: 19564950 DOI: 10.3390/ijms10052252] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
43 Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, Suh KS, Lee HS. Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth. Cancer Lett 2008;271:314-22. [PMID: 18657357 DOI: 10.1016/j.canlet.2008.06.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
44 Kim DJ, Vo MT, Choi SH, Lee JH, Jeong SY, Hong CH, Kim JS, Lee UH, Chung HM, Lee BJ, Cho WJ, Park JW. Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells. Mol Biol Cell 2019;30:542-53. [PMID: 30650008 DOI: 10.1091/mbc.E18-09-0606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Gershon TR, Crowther AJ, Tikunov A, Garcia I, Annis R, Yuan H, Miller CR, Macdonald J, Olson J, Deshmukh M. Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma. Cancer Metab 2013;1:2. [PMID: 24280485 DOI: 10.1186/2049-3002-1-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
46 Vassilaki N, Kalliampakou KI, Kotta-Loizou I, Befani C, Liakos P, Simos G, Mentis AF, Kalliaropoulos A, Doumba PP, Smirlis D, Foka P, Bauhofer O, Poenisch M, Windisch MP, Lee ME, Koskinas J, Bartenschlager R, Mavromara P. Low oxygen tension enhances hepatitis C virus replication. J Virol 2013;87:2935-48. [PMID: 23269812 DOI: 10.1128/JVI.02534-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
47 Luo F, Li Y, Yuan F, Zuo J. Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase. Chin J Cancer Res 2019;31:521-32. [PMID: 31354221 DOI: 10.21147/j.issn.1000-9604.2019.03.14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ciscato F, Ferrone L, Masgras I, Laquatra C, Rasola A. Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters. Int J Mol Sci 2021;22:4716. [PMID: 33946854 DOI: 10.3390/ijms22094716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken). 2008;291:721-734. [PMID: 18484619 DOI: 10.1002/ar.20668] [Cited by in Crossref: 112] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
50 Yeluri S, Madhok B, Prasad KR, Quirke P, Jayne DG. Cancer’s craving for sugar: an opportunity for clinical exploitation. J Cancer Res Clin Oncol 2009;135:867-77. [DOI: 10.1007/s00432-009-0590-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
51 Li YM, Yao DF. Molecular composition, activation mechanism of hypoxia-inducible factor-1 and targeted therapy of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(27): 3070-3076 [DOI: 10.11569/wcjd.v16.i27.3070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Liu ZG, Ding J, Du C, Xu N, Wang EL, Li JY, Wang YY, Yu JM. Phosphoglycerate mutase 1 is highly expressed in C6 glioma cells and human astrocytoma. Oncol Lett 2018;15:8935-40. [PMID: 29805628 DOI: 10.3892/ol.2018.8477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Rissanen E, Tranberg HK, Nikinmaa M. Oxygen availability regulates metabolism and gene expression in trout hepatocyte cultures. Am J Physiol Regul Integr Comp Physiol 2006;291:R1507-15. [PMID: 16778071 DOI: 10.1152/ajpregu.00025.2006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
54 Kobliakov VA. Mechanisms of tumor promotion by reactive oxygen species. Biochemistry (Mosc) 2010;75:675-85. [PMID: 20636258 DOI: 10.1134/s0006297910060015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
55 Vali M, Liapi E, Kowalski J, Hong K, Khwaja A, Torbenson MS, Georgiades C, Geschwind JF. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol. 2007;18:95-101. [PMID: 17296709 DOI: 10.1016/j.jvir.2006.10.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
56 Zhou C, Liu J, Tang Y, Zhu G, Zheng M, Jiang J, Yang J, Liang X. Coexpression of hypoxia-inducible factor-2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma. J Oral Pathol Med. 2012;41:424-431. [PMID: 22103974 DOI: 10.1111/j.1600-0714.2011.01114.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
57 Vanichapol T, Leelawat K, Hongeng S. Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal‑regulated kinase signaling pathway. Mol Med Rep 2015;12:3265-72. [PMID: 26018028 DOI: 10.3892/mmr.2015.3865] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
58 Campbell AM, Chan SH. The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Archives of Biochemistry and Biophysics 2007;466:203-10. [DOI: 10.1016/j.abb.2007.06.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
59 Legendre C, Hori T, Loyer P, Aninat C, Ishida S, Glaise D, Lucas-Clerc C, Boudjema K, Guguen-Guillouzo C, Corlu A, Morel F. Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression. Eur J Cancer 2009;45:2882-92. [PMID: 19695866 DOI: 10.1016/j.ejca.2009.07.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
60 Park HS, Chung JW, Jae HJ, Kim YI, Son KR, Lee MJ, Park JH, Kang WJ, Yoon JH, Chung H, Lee K. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model. Korean J Radiol 2007;8:216-24. [PMID: 17554189 DOI: 10.3348/kjr.2007.8.3.216] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
61 Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY, Yoon JH. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. Biomed Pharmacother 2016;83:607-16. [PMID: 27459117 DOI: 10.1016/j.biopha.2016.07.027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
62 Wu XZ, Xie GR, Chen D. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:1178-82. [PMID: 17559361 DOI: 10.1111/j.1440-1746.2007.04997.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 8.8] [Reference Citation Analysis]
63 Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma. Anticancer Drugs 2012;23:597-605. [PMID: 22273827 DOI: 10.1097/CAD.0b013e3283503fbc] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
64 Lat I, Foster DR, Erstad B. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med. 2010;38:S175-S187. [PMID: 20502172 DOI: 10.1097/ccm.0b013e3181de0db2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Wang SH, Chen LM, Yang WK, Lee JD. Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization. World J Gastroenterol 2011; 17(42): 4675-4681 [PMID: 22180709 DOI: 10.3748/wjg.v17.i42.4675] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
66 Chang JM, Chung JW, Jae HJ, Eh H, Son KR, Lee KC, Park JH. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model. Acad Radiol 2007;14:85-92. [PMID: 17178370 DOI: 10.1016/j.acra.2006.09.059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
67 Chang CW, Lo JF, Wang XW. Roles of mitochondria in liver cancer stem cells. Differentiation 2019;107:35-41. [PMID: 31176254 DOI: 10.1016/j.diff.2019.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
68 Gong L, Cui Z, Chen P, Han H, Peng J, Leng X. Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II. Med Oncol. 2012;29:909-914. [PMID: 21279699 DOI: 10.1007/s12032-011-9841-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
69 Bodur C, Karakas B, Timucin AC, Tezil T, Basaga H. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins. Mol Carcinog 2016;55:1584-97. [PMID: 26373689 DOI: 10.1002/mc.22411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
70 Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009;174:1544-52. [PMID: 19286567 DOI: 10.2353/ajpath.2009.080596] [Cited by in Crossref: 179] [Cited by in F6Publishing: 184] [Article Influence: 13.8] [Reference Citation Analysis]
71 Lewandowski RJ, Wang D, Gehl J, Atassi B, Ryu RK, Sato K, Nemcek AA Jr, Miller FH, Mulcahy MF, Kulik L, Larson AC, Salem R, Omary RA. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol 2007;18:1249-57. [PMID: 17911515 DOI: 10.1016/j.jvir.2007.06.028] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
72 Lee JH, Yoon JH, Yu SJ, Chung GE, Jung EU, Kim HY, Kim BH, Choi DH, Myung SJ, Kim YJ, Kim CY, Lee HS. Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells. Cancer Lett 2010;295:229-35. [PMID: 20350780 DOI: 10.1016/j.canlet.2010.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
73 Li XF, Du Y, Ma Y, Postel GC, Civelek AC. (18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application. Transl Oncol 2014;7:240-7. [PMID: 24699008 DOI: 10.1016/j.tranon.2014.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
74 Wen J, Luo Y, Gao H, Zhang L, Wang X, Huang J, Shang T, Zhou D, Wang D, Wang Z, Li P, Wang Z. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor. J Nanobiotechnology 2021;19:440. [PMID: 34930284 DOI: 10.1186/s12951-021-01196-6] [Reference Citation Analysis]
75 Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett 2010;298:9-15. [PMID: 20573444 DOI: 10.1016/j.canlet.2010.05.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
76 Ehrke E, Arend C, Dringen R. 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes: 3-BP and Astrocytes. Journal of Neuroscience Research 2015;93:1138-46. [DOI: 10.1002/jnr.23474] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
77 Simioni C, Cani A, Martelli AM, Zauli G, Alameen AA, Ultimo S, Tabellini G, McCubrey JA, Capitani S, Neri LM. The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget 2015;6:17147-60. [PMID: 26003166 DOI: 10.18632/oncotarget.3940] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
78 Bao MH, Wong CC. Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer. Cells 2021;10:1715. [PMID: 34359884 DOI: 10.3390/cells10071715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Zhang J, Li H, Huang Z, He Y, Zhou X, Huang T, Dai P, Duan D, Ma X, Yin Q, Wang X, Liu H, Chen S, Zou F, Chen X. Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells. Cell Stress Chaperones 2016;21:339-48. [PMID: 26786409 DOI: 10.1007/s12192-015-0664-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
80 Tal R, Shaish A, Rofe K, Feige E, Varda-bloom N, Afek A, Barshack I, Bangio L, Hodish I, Greenberger S, Peled M, Breitbart E, Harats D. Endothelial-targeted Gene Transfer of Hypoxia-inducible Factor-1α Augments Ischemic Neovascularization Following Systemic Administration. Molecular Therapy 2008;16:1927-36. [DOI: 10.1038/mt.2008.191] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
81 Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, Zhou J, Zhang BH, Fan J. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 2009;9:418. [PMID: 19948069 DOI: 10.1186/1471-2407-9-418] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
82 Smith RW, Cash P, Hogg DW, Buck LT. Proteomic changes in the brain of the western painted turtle (Chrysemys picta bellii) during exposure to anoxia. Proteomics 2015;15:1587-97. [PMID: 25583675 DOI: 10.1002/pmic.201300229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
83 Hompland T, Fjeldbo CS, Lyng H. Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter. Cancers (Basel) 2021;13:499. [PMID: 33525508 DOI: 10.3390/cancers13030499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
84 Yu SJ, Won JK, Ryu HS, Choi WM, Cho H, Cho EJ, Lee JH, Kim YJ, Suh KS, Jang JJ, Kim CY, Lee HS, Yoon JH, Cho KH. A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase. Korean J Intern Med 2014;29:580-7. [PMID: 25228833 DOI: 10.3904/kjim.2014.29.5.580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
85 Adamski JK, Estlin EJ, Makin GW. The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer. Cancer Treat Rev 2008;34:231-46. [PMID: 18207646 DOI: 10.1016/j.ctrv.2007.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
86 Shin S, Kwon YJ, Ye DJ, Baek HS, Kwon TU, Kim D, Chun YJ. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes. Biochim Biophys Acta Mol Basis Dis 2019;1865:2464-74. [PMID: 31195119 DOI: 10.1016/j.bbadis.2019.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Bedessem B, Stéphanou A. Role of compartmentalization on HiF-1α degradation dynamics during changing oxygen conditions: a computational approach. PLoS One 2014;9:e110495. [PMID: 25338163 DOI: 10.1371/journal.pone.0110495] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ho N, Morrison J, Silva A, Coomber BL. The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression. Biosci Rep 2016;36:e00299. [PMID: 26740252 DOI: 10.1042/BSR20150267] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
89 Lin D, Wu J. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. World J Gastroenterol 2015; 21(42): 12171-12178 [PMID: 26576101 DOI: 10.3748/wjg.v21.i42.12171] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 70] [Article Influence: 8.4] [Reference Citation Analysis]
90 Dai Q, Yin Y, Liu W, Wei L, Zhou Y, Li Z, You Q, Lu N, Guo Q. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. The International Journal of Biochemistry & Cell Biology 2013;45:1468-78. [DOI: 10.1016/j.biocel.2013.04.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
91 Dou C, Zhou Z, Xu Q, Liu Z, Zeng Y, Wang Y, Li Q, Wang L, Yang W, Liu Q, Tu K. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway. Oncogene. 2019;38:1239-1255. [PMID: 30250300 DOI: 10.1038/s41388-018-0505-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
92 Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ 2015;22:248-57. [PMID: 25323588 DOI: 10.1038/cdd.2014.173] [Cited by in Crossref: 171] [Cited by in F6Publishing: 174] [Article Influence: 21.4] [Reference Citation Analysis]
93 Srivastava S, Thakkar B, Yeoh KG, Ho KY, Teh M, Soong R, Salto-tellez M. Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma. Virchows Arch 2015;466:541-8. [DOI: 10.1007/s00428-015-1745-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
94 Hervouet E, Godinot C. Mitochondrial disorders in renal tumors. Mitochondrion 2006;6:105-17. [DOI: 10.1016/j.mito.2006.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
95 Pazo-Cid RA, Lanzuela M, Esquerdo G, Pérez-Gracia JL, Antón A, Amigo G, Trufero JM, García-Otín AL, Martín-Duque P. Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC). Clin Transl Oncol 2012;14:564-74. [PMID: 22855137 DOI: 10.1007/s12094-012-0842-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
96 Fan T, Sun G, Sun X, Zhao L, Zhong R, Peng Y. Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment. Cancers (Basel) 2019;11:E317. [PMID: 30845728 DOI: 10.3390/cancers11030317] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 15.0] [Reference Citation Analysis]
97 Wang Y, Takeishi K, Li Z, Cervantes-Alvarez E, Collin de l'Hortet A, Guzman-Lepe J, Cui X, Zhu J. Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks. Organogenesis. 2017;13:83-94. [PMID: 28548903 DOI: 10.1080/15476278.2017.1322243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
98 Mossenta M, Busato D, Dal Bo M, Toffoli G. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers (Basel) 2020;12:E1668. [PMID: 32585931 DOI: 10.3390/cancers12061668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
99 Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. PLoS One 2014;9:e115565. [PMID: 25531114 DOI: 10.1371/journal.pone.0115565] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
100 Díaz-Juárez JA, Hernández-Muñoz R. Rat Liver Enzyme Release Depends on Blood Flow-Bearing Physical Forces Acting in Endothelium Glycocalyx rather than on Liver Damage. Oxid Med Cell Longev 2017;2017:1360565. [PMID: 28337244 DOI: 10.1155/2017/1360565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
101 Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY, Yoon JH. Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma. Dig Dis Sci 2016;61:2568-77. [PMID: 27074919 DOI: 10.1007/s10620-016-4158-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
102 Tak E, Jun DY, Kim SH, Park GC, Lee J, Hwang S, Song GW, Lee SG. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells. J Int Med Res 2016;44:1234-47. [PMID: 27807254 DOI: 10.1177/0300060516662135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
103 Zhang X, Ng HLH, Lu A, Lin C, Zhou L, Lin G, Zhang Y, Yang Z, Zhang H. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future. Nanomedicine. 2016;12:853-869. [PMID: 26772424 DOI: 10.1016/j.nano.2015.12.381] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 11.0] [Reference Citation Analysis]
104 Wang Y, Zhang Y, Huang Y, Chen C, Zhang X, Xing Y, Gu Y, Zhang M, Cai L, Xu S, Sun B. Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment. Theranostics 2021;11:4403-20. [PMID: 33754068 DOI: 10.7150/thno.53737] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
105 Schobert IT, Savic LJ. Current Trends in Non-Invasive Imaging of Interactions in the Liver Tumor Microenvironment Mediated by Tumor Metabolism. Cancers (Basel) 2021;13:3645. [PMID: 34359547 DOI: 10.3390/cancers13153645] [Reference Citation Analysis]
106 Sun L, Lin P, Qin Z, Liu Y, Deng LL, Lu C. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation. Exp Biol Med (Maywood) 2015;240:1434-45. [PMID: 25681470 DOI: 10.1177/1535370215570205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
107 Jang ES, Yoon J, Lee S, Lee S, Lee J, Yu SJ, Kim YJ, Lee H, Kim CY. Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation. J Cancer Res Clin Oncol 2014;140:133-44. [DOI: 10.1007/s00432-013-1554-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
108 Garcia SN, Guedes RC, Marques MM. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. Curr Med Chem 2019;26:7285-322. [PMID: 30543165 DOI: 10.2174/0929867326666181213092652] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]